Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Gross Profit: 2009-2024

Historic Gross Profit for Myriad Genetics (MYGN) over the last 16 years, with Dec 2024 value amounting to $585.4 million.

  • Myriad Genetics' Gross Profit fell 4.01% to $143.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $580.7 million, marking a year-over-year increase of 12.43%. This contributed to the annual value of $585.4 million for FY2024, which is 13.23% up from last year.
  • According to the latest figures from FY2024, Myriad Genetics' Gross Profit is $585.4 million, which was up 13.23% from $517.0 million recorded in FY2023.
  • In the past 5 years, Myriad Genetics' Gross Profit ranged from a high of $585.4 million in FY2024 and a low of $399.2 million during FY2020.
  • Its 3-year average for Gross Profit is $526.3 million, with a median of $517.0 million in 2023.
  • As far as peak fluctuations go, Myriad Genetics' Gross Profit decreased by 29.55% in 2020, and later rose by 26.48% in 2021.
  • Myriad Genetics' Gross Profit (Yearly) stood at $481.1 million in 2020, then reached $399.2 million in 2020, then rose by 26.48% to $504.9 million in 2021, then decreased by 5.64% to $476.4 million in 2022, then increased by 8.52% to $517.0 million in 2023, then climbed by 13.23% to $585.4 million in 2024.